(Alliance News) - Vodafone Group PLC on Wednesday said the former chief financial officer of drugs maker GSK PLC will join its board as a non-executive director.
The Berkshire, England-based telecommunications provider said Simon Dingemans will join the board on January 1 and stand for election by shareholders for the first time at Vodafone's 2025 annual general meeting.
The company has yet to published the meeting's date. It is scheduled to provide a financial third-quarter trading update on February 4 and its annual results on May 20.
Dingemans served as CFO of GSK from 2011 to 2019, where he led efficiency programmes and helped restructure the group into two distinct biopharma and consumer healthcare businesses. The consumer side subsequently was spun-off and separately listed as Haleon PLC in 2022.
Prior to his role at GSK, Dingemans worked at investment banks SG Warburg and Goldman Sachs Group Inc, where was a partner and head of UK investment banking. Dingemans has also served as chair of the UK Fnancial Reporting Council.
He currently chairs healthcare company Genomics Ltd and the mutual funds network Calastone Ltd, a subsidiary of the Carlyle Group. He is also a non-executive director of the ad agency WPP PLC.
Vodafone Chair Jean-François van Boxmeer said Dingemans's combined "financial, operational and strategic experience" would help the Vodafone "achieve our commercial priorities and deliver long-term value".
Vodafone shares were down 0.1% at 70.24 pence each on Wednesday morning in London.
By Holly Munks, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Vodafone (VOD)
Glaxosmithkline (GSK)
Haleon (HLN)
WPP (WPP)
